Clinical Trial Update: A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating relapse prevention using long-acting injectable risperidone and quetiapine tablets in patients with schizophrenia or schizoaffective di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Quetiapine Tablets (Quetiapine)
• Risperidone long-acting injectable (Risperdal Consta) (Risperidone)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Schizophrenia, Psychotic Disorders | Phase 3 | Status: COMPLETED | Results posted: 2010-08-10